MarketsandMarkets: Top 10 Drug Delivery Technologies Market to be US$156 Billion by 2015By Marketsandmarkets, PRNE
Wednesday, January 19, 2011
DALLAS, January 20, 2011 - The 'Top 10 Drug Delivery Technologies Market (2010 - 2015)' analyzes the
drug delivery technologies market by the top 10 drug delivery technologies
and studies the major market drivers, restraints, and opportunities in North
America, Europe, Asia and ROW.
Browse 75 market data tables and in-depth TOC on Top 10 Drug Delivery
Technologies Market: Global Forecast.
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)
Early buyers will receive 10% customization of reports.
The rising demand for effective delivery of novel biopharmaceuticals is
driving the growth of the global top 10 drug delivery technologies market.
Further, drug patent expiration is also boosting market growth. The top 10
drug delivery technologies market is expected to grow from 77 billion in 2009
to 156 billion in 2015, at an estimated CAGR of 17% from 2010 to 2015.
Prominent industry participants include Elan, Biovail, Alkermes & Nektar.
Each sub-segment of the top 10 drug delivery technologies market is
calculated for the four geographies of North America, Europe, Asia, and Rest
of the World (ROW). North America is leading the market in 2009 with a 41%
revenue share followed by European market contributing to 30% in 2009 which
is expected to become the largest market in 2015 at $49.5 billion, growing at
a CAGR of 18.7% during 2010 - 2015.
Controlled release technology market account for the largest share with
$20 billion revenue in 2010 and is expected to grow at a CAGR of 10.2% during
Unconventional modes of drug delivery such as pulmonary, nasal
and transdermal are gaining a lot of popularity especially in chronic disease
conditions such as diabetes, hypertension, CNS and cancer. Nanotechnology
advances have led to the development of innovative drug delivery systems.
Drug delivery technologies are revenue boosters for the
pharmaceutical industry as they enhance drug life cycle in the market by
extending patent rights, adding a competitive edge to the drug by enhancing
their safety and efficacy. Further, expansion of the applications of non
conventional modes of drug delivery such as pulmonary, nasal and transdermal
in disease conditions other than respiratory and skin, especially in chronic
disease conditions such as diabetes, CNS are also boosting the market. In
addition, innovations such as microneedle transdermal patches and novel
intelligent inhalers are also adding to the market growth. However, increase
in drug failures, pricing pressure, reimbursement issues and third party
dependence are challenges for the market.
Currently, market players are focusing in the development and
commercialization of new drugs through agreements and collaborations which
therefore accounted for the highest share of the total competitive
developments in the global top 10 drug delivery technologies market from 2007
to June 2010.
Scope of the report
The report analyzes Top 10 drug delivery technologies market
including their market sizes and forecasts. It also provides a detailed
analysis of the market trends, factors influencing market growth and in-depth
geographic analyses in North America, Europe, Asia, and Rest of the World
(ROW) markets. The report draws competitive landscape, comparative analysis
of the technological and marketing strategies the key players are adopting in
order to gain an edge over the their competitors
This research report categorizes the top 10 drug delivery
technologies on the basis of their growth, therapeutic areas, patents, and
industry focus of the following sub categories:
- Controlled release technologies - Targeted delivery - Inhaler device technology - Encapsulation technology - Topical formulations - Injectable device technology - Trandermal patch - Implantable drug delivery technology - Liposomal drug delivery - PEGlyation technology
- Manufacturers, suppliers, and dealers of drug delivery technologies - Pharmaceutical and biotech companies - Healthcare providers - Potential investors in the drug delivery technologies market
MarketsandMarkets (M&M) is a global market research and consulting
company based in the U.S. We publish strategically analyzed market research
reports and serve as a business intelligence partner to Fortune 500 companies
across the world. MarketsandMarkets also provides multi-client reports,
company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials,
automotive and transportation, banking and financial services, biotechnology,
chemicals, consumer goods energy and power, food and beverages, industrial
automation, medical devices, pharmaceuticals, semiconductor and electronics,
and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by
providing apt business insight with our huge market intelligence repository.
To know more about us and our reports, please visit our website
Mr. Rohan 7557 Rambler Road, Suite 727, Dallas, TX 75231 Tel: +1-888-600-6441 Email: firstname.lastname@example.org www.marketsandmarkets.com marketsandmarkets.blogspot.com
Contact: Mr. Rohan, 7557 Rambler Road, Suite 727, Dallas, TX 75231, Tel: +1-888-600-6441, Email: sales at marketsandmarkets.com
Tags: Dallas, January 20, MarketsandMarkets, texas